Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

General Use-results Survey of Alunbrig Tablets "Non-small Cell Lung Cancer"

NCT05100069 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT05100069
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05100069 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
General Use-results Survey of Alunbrig Tablets "Non-small Cell Lung Cancer"
Lead sponsor
Takeda
Phase
Observational
Overall status
Recruiting
Start date
November 1, 2021
Completion date
September 30, 2030
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer (nsclc)